JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB2410

Anti-Human IgG antibody

Be the first to review this product! Submit a review

|

(87 Publications)

Rabbit Polyclonal IGHG1 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 87 publications. Immunogen corresponding to Native Full Length Protein corresponding to Human IGHG1.

View Alternative Names

Immunoglobulin heavy constant gamma 1, Ig gamma-1 chain C region, Ig gamma-1 chain C region EU, Ig gamma-1 chain C region KOL, Ig gamma-1 chain C region NIE, IGHG1

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Human IgG antibody (AB2410)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Human IgG antibody (AB2410)

ab2410 staining IgG in human tonsil sections

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

Unknown

Light chain type

unknown

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Native Full Length Protein corresponding to Human IGHG1.

P01857

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/200 - 1/500", "IHCP-species-notes": "<p></p> Perform enzymatic antigen retrieval before commencing with IHC staining protocol." } } }

Properties and storage information

Form
Liquid
Purification technique
Proprietary technique
Storage buffer
pH: 7.3 - 7.5 Preservative: 0.05% Sodium azide Constituents: 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Constant region of immunoglobulin (Ig) heavy chains. Igs are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound Igs serve as receptors, which upon binding to a specific antigen trigger the clonal expansion and differentiation of B lymphocytes into Ig-secreting plasma cells. Secreted Igs known as antibodies mediate the effector phase of humoral immunity by blocking the interaction of infectious antigens with cellular receptors (via the antigen-binding region) and eliciting effector mechanisms that lead to pathogen neutralization (via the constant region) (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The antigen-binding region is formed by the variable domain of one heavy chain paired with the variable domain of its associated light chain. Each Ig molecule has two antigen-binding sites with remarkable affinity for a particular antigen due to V-(D)-J rearrangement, somatic hypermutations and affinity maturation of the variable domains upon antigen exposure (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region defines the Ig isotype that perform distinct sets of effector functions. B cells diversify and rearrange their Ig constant regions through class-switch recombination, a process by which the constant region is switched from one Ig isotype to another, namely from IgM and IgD to IgG, IgA and IgE (PubMed : 17576170, PubMed : 20176268, PubMed : 22158414). The constant region of Ig gamma-1 (IgG1) isotype interacts (via the fragment crystallizable, Fc) with receptors on innate immune cells and the complement system to mediate humoral effector functions, including antibody-dependent cellular cytotoxicity or phagocytosis, complement-dependent cytotoxicity and inflammatory responses.
See full target information IGHG1

Publications (87)

Recent publications for all applications. Explore the full list and refine your search

Clinical epigenetics 17:146 PubMed40886022

2025

Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMT/DGKI glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jean-Maxime Besson,Amandine Etcheverry,Arulraj Nadaradjane,Gwenola Bougras-Cartron,Marc Aubry,Jean-Sebastien Frenel,Alain Chevanieu,Marie Lopez,Jean Mosser,Pierre-François Cartron

Renal failure 46:2403649 PubMed39311631

2024

protein targeted activation of -mediated PANoptosis promotes sepsis-induced acute kidney injury.

Applications

Unspecified application

Species

Unspecified reactive species

Siwei Wei,Lei Wu,Zhen Xiang,Xiaoxiao Yang,Dongjie Pei,Liubing Jiang,Zhen Du

Annual review of pharmacology and toxicology 65:333-354 PubMed39259979

2024

Gut Microbiota-Related Biomarkers in Immuno-Oncology.

Applications

Unspecified application

Species

Unspecified reactive species

Carolina Alves Costa Silva,Marine Fidelle,Andrew A Almonte,Lisa Derosa,Laurence Zitvogel

Neurobiology of disease 199:106564 PubMed38876323

2024

Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout mice.

Applications

Unspecified application

Species

Unspecified reactive species

Manon Fortier,Margaux Cauhapé,Suzie Buono,Julien Becker,Alexia Menuet,Julien Branchu,Ivana Ricca,Serena Mero,Karim Dorgham,Khalid-Hamid El Hachimi,Kostantin Dobrenis,Benoit Colsch,Dominic Samaroo,Morgan Devaux,Alexandra Durr,Giovanni Stevanin,Filippo M Santorelli,Sophie Colombo,Belinda Cowling,Frédéric Darios

Journal of orthopaedic surgery and research 19:212 PubMed38561786

2024

CYLD alleviates NLRP3 inflammasome-mediated pyroptosis in osteoporosis by deubiquitinating WNK1.

Applications

Unspecified application

Species

Unspecified reactive species

Guiyong Jiang,Yu Cai,Duo Cheng,Hao Wang,Geyang Deng,Dayong Xiang

American journal of human genetics 111:509-528 PubMed38412861

2024

Haploinsufficiency of ZFHX3, encoding a key player in neuronal development, causes syndromic intellectual disability.

Applications

Unspecified application

Species

Unspecified reactive species

María Del Rocío Pérez Baca,Eva Z Jacobs,Lies Vantomme,Pontus Leblanc,Elke Bogaert,Annelies Dheedene,Laurenz De Cock,Sadegheh Haghshenas,Aidin Foroutan,Michael A Levy,Jennifer Kerkhof,Haley McConkey,Chun-An Chen,Nurit Assia Batzir,Xia Wang,María Palomares,Marieke Carels,Bart Dermaut,Bekim Sadikovic,Björn Menten,Bo Yuan,Sarah Vergult,Bert Callewaert

Molecular carcinogenesis 63:629-646 PubMed38226841

2024

circRNA TATA-box binding protein associated factor 15 acts as an oncogene to facilitate bladder cancer progression through targeting miR-502-5p/high mobility group box 3.

Applications

Unspecified application

Species

Unspecified reactive species

Hong Yang,Peilin He,Wei Luo,Shaoyou Liu,Yong Yang

Journal of orthopaedic surgery and research 18:766 PubMed37817257

2023

Paeoniflorin shows chondroprotective effects under IL-1β stress by regulating circ-PREX1/miR-140-3p/WNT5B axis.

Applications

Unspecified application

Species

Unspecified reactive species

Lan'e Wu,Runke Tang,Weibiao Xiong,Shuhua Song,Qian Guo,Qingqing Zhang

Cancers 15: PubMed37370798

2023

Adenosine Methylation Level of miR-125a-5p Promotes Anti-PD-1 Therapy Escape through the Regulation of IGSF11/VSIG3 Expression.

Applications

Unspecified application

Species

Unspecified reactive species

Gwenola Bougras-Cartron,Arulraj Nadaradjane,Marie-Pierre Joalland,Lisenn Lalier-Bretaudeau,Judith Raimbourg,Pierre-François Cartron

Laboratory investigation; a journal of technical methods and pathology 101:600-611 PubMed36775382

2023

EZH2 is associated with cartilage degeneration in osteoarthritis by promoting SDC1 expression via histone methylation of the microRNA-138 promoter.

Applications

Unspecified application

Species

Unspecified reactive species

Jian Wang,Xiang Wang,Xu Ding,Tao Huang,Dengxin Song,Hairong Tao
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com